Eagle Pharmaceuticals Stock (NASDAQ:EGRX), Quotes and News Summary

Q: What sector and industry does Eagle Pharmaceuticals (EGRX) operate in?

Eagle Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Eagle Pharmaceuticals Stock (NASDAQ: EGRX) stock price, news, charts, stock research, profile.

Open	$4.360
Close	$4.480
Volume / Avg.	135.741K / 212.212K
Day Range	4.360 - 4.750
52 Wk Range	4.100 - 30.430
Market Cap	$58.053M
P/E Ratio	5.141
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	14.47%
Days to Cover	10.49

Recent News

Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.

Lisa Levin

Why Is Eagle Pharmaceuticals Stock Trading Lower Today?

Eagle Pharmaceuticals Inc's (NASDAQ: EGRX) Scott Tarriff, founder, president, and Chief Executive Officer, announced his resignation and retirement,

Vandana Singh

Top 4 Health Care Stocks That Could Blast Off This Quarter

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

2.5

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

About Eagle Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercial...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Eagle Pharmaceuticals (EGRX) stock?

You can purchase shares of Eagle Pharmaceuticals (NASDAQ: EGRX) through any online brokerage.

View our list of the best stock brokerages.

Who are Eagle Pharmaceuticals's (EGRX) competitors?

Other companies in Eagle Pharmaceuticals’s space includes: Kezar Life Sciences (NASDAQ:KZR), Vaxxinity (NASDAQ:VAXX), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and Immuneering (NASDAQ:IMRX).

What is the target price for Eagle Pharmaceuticals (EGRX) stock?

The latest price target for Eagle Pharmaceuticals (NASDAQ: EGRX) was reported by Piper Sandler on Wednesday, August 9, 2023. The analyst firm set a price target for 17.00 expecting EGRX to rise to within 12 months (a possible 279.46% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Eagle Pharmaceuticals (EGRX)?

The stock price for Eagle Pharmaceuticals (NASDAQ: EGRX) is $4.48 last updated Today at April 18, 2024 at 4:00 PM EDT.

Does Eagle Pharmaceuticals (EGRX) pay a dividend?

There are no upcoming dividends for Eagle Pharmaceuticals.

When is Eagle Pharmaceuticals (NASDAQ:EGRX) reporting earnings?

Eagle Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Is Eagle Pharmaceuticals (EGRX) going to split?

There is no upcoming split for Eagle Pharmaceuticals.

What sector and industry does Eagle Pharmaceuticals (EGRX) operate in?

Eagle Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-